Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Nucleic Acid Amplification Testing Market: By Technique, By Application, Cancer, Personalized Medicine, and Genetic and Mitochondrial Disorders), and Geography
Nucleic Acid Amplification Testing Market size was valued at US$ 1,951.4 million in 2023 and is poised to grow at a CAGR of 9.4% from 2024 to 2030. One advantage of signal amplification systems is that they provide more options for target recognition sequences in some circumstances. The increased prevalence of infectious diseases, the rising need for better diagnostic measures, and rising investment in developing new biotechnological diagnostic procedures are driving the nucleic acid amplification testing market. Furthermore, nucleic acid amplification testing delivers the most exact detection. It is thus frequently preferred over older methods, owing to the growing need for improved testing methods and the biopharmaceutical industry's increased R&D expenditure. However, the lack of skilled professionals and high costs hampers the nucleic acid amplification testing market. For COVID-19 (SARS-CoV-2), a Nucleic Acid Amplification Test (NAAT) is a form of a viral diagnostic test. NAATs are genetic material detectors (nucleic acids). SARS-CoV-2 NAATs identify the RNA (ribonucleic acid) sequences that make up the virus's genetic material.
Moreover, rise in R&D for the development of advanced technologies for nucleic acid testing, an increase in demand for early-stage disease diagnosis and personalized medicine, rise in funding from public and private sectors for the healthcare infrastructure development, and surge in demand for nucleic acid testing from blood banks are anticipated to boost the market over the forecast timeframe. However, stringent regulatory guidelines, high cost and complexity in the testing, and lack of skilled professionals and sophisticated healthcare infrastructure in underdeveloped countries are hinder the growth of market in future years.
For instance, according to WHO 2018 data, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, rise in R&D for the development of advanced technologies for nucleic acid testing, increased in demand for early stage disease diagnosis and personalized medicine, raise in funding from public and private sectors for the healthcare infrastructure development, and surge in demand for nucleic acid testing from blood banks are anticipated to boost the market over the forecast timeframe. However, stringent regulatory guidelines, high cost and complexity in the testing, and lack of skilled professionals and sophisticated healthcare infrastructure in underdeveloped countries are hinder the growth of market in future years.
In January 2021, Xpert Xpress SARS-CoV-2 of Cepheid was launched for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper respiratory specimens.
Study Period
2024-2030Base Year
2023CAGR
9.4%Largest Market
Asia PacificFastest Growing Market
North America
Nucleic Acid Amplification Testing market is surging owing to frequent acquisitions and launchings by the market players. Strategic alliances by the players such as acquisitions, mergers, expansions, and new product launches may enhance the company's growth. For instance, In March 2020, Abbott launched Abbott's point-of-care ID NOW platform, a molecular point-of-care test to detect novel coronavirus in as little as five minutes
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 1,951.4 million |
Market CAGR |
9.4% |
By Technique |
|
By Application |
|
By Region |
|
Download Free Sample Report
The nucleic acid amplification testing market is projected to expand at a CAGR of 9.4% during the forecast period.
Hoffmann-La Roche, Becton, Dickinson and Company, Beckman Coulter, Abbott Laboratories, Illumina, Siemens Healthineers
North America is dominating the nucleic acid amplification testing market
1.Executive Summary |
2.Global Nucleic Acid Amplification Testing Market Introduction |
2.1.Global Nucleic Acid Amplification Testing Market - Taxonomy |
2.2.Global Nucleic Acid Amplification Testing Market - Definitions |
2.2.1. By Technique |
2.2.2. By Application |
2.2.3. By Region |
3.Global Nucleic Acid Amplification Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Nucleic Acid Amplification Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Nucleic Acid Amplification Testing Market By Technique, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Target amplification systems |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Probe amplification systems |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Signal amplification |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Nucleic Acid Amplification Testing Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Infectious Diseases |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Cancer |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Personalized Medicine |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Genetic and Mitochondrial Disorders |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Nucleic Acid Amplification Testing Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Target amplification systems |
8.1.2.Probe amplification systems |
8.1.3.Signal amplification |
8.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Infectious Diseases |
8.2.2.Cancer |
8.2.3.Personalized Medicine |
8.2.4.Genetic and Mitochondrial Disorders |
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Target amplification systems |
9.1.2.Probe amplification systems |
9.1.3.Signal amplification |
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Infectious Diseases |
9.2.2.Cancer |
9.2.3.Personalized Medicine |
9.2.4.Genetic and Mitochondrial Disorders |
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Target amplification systems |
10.1.2.Probe amplification systems |
10.1.3.Signal amplification |
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Infectious Diseases |
10.2.2.Cancer |
10.2.3.Personalized Medicine |
10.2.4.Genetic and Mitochondrial Disorders |
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Target amplification systems |
11.1.2.Probe amplification systems |
11.1.3.Signal amplification |
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Infectious Diseases |
11.2.2.Cancer |
11.2.3.Personalized Medicine |
11.2.4.Genetic and Mitochondrial Disorders |
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Target amplification systems |
12.1.2.Probe amplification systems |
12.1.3.Signal amplification |
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Infectious Diseases |
12.2.2.Cancer |
12.2.3.Personalized Medicine |
12.2.4.Genetic and Mitochondrial Disorders |
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Hoffmann-La Roche |
13.2.2.Becton |
13.2.3.Dickinson and Company |
13.2.4.Beckman Coulter |
13.2.5.Abbott Laboratories |
13.2.6.Illumina |
13.2.7.Siemens Healthineers |
13.2.8.bioMerieux |
13.2.9.Novartis |
13.2.10.Bio-Rad Laboratories |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players